|
1
|
Cong WM, Dong H, Tan L, Sun XX and Wu MC:
Surgicopathological classification of hepatic space-occupying
lesions: A single-center experience with literature review. World J
Gastroenterol. 17:2372–2378. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakayama H and Takayama T: Role of
surgical resection for hepatocellular carcinoma based on Japanese
clinical guidelines for hepatocellular carcinoma. World J Hepatol.
7:261–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petrelli F, Coinu A, Cabiddu M, Ghilardi
M, Borgonovo K, Lonati V and Barni S: Hepatic resection for gastric
cancer liver metastases: A systematic review and meta-analysis. J
Surg Oncol. 111:1021–1027. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lencioni R, Petruzzi P and Crocetti L:
Chemoembolization of hepatocellular carcinoma. Semin Intervent
Radiol. 30:3–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim HY and Park JW: Clinical trials of
combined molecular targeted therapy and locoregional therapy in
hepatocellular carcinoma: Past, present, and future. Liver Cancer.
3:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gnoni A, Santini D, Scartozzi M, Russo A,
Licchetta A, Palmieri V, Lupo L, Faloppi L, Palasciano G, Memeo V,
et al: Hepatocellular carcinoma treatment over sorafenib:
Epigenetics, microRNAs and microenvironment. Is there a light at
the end of the tunnel? Expert Opin Ther Targets. 19:1623–1635.
2015. View Article : Google Scholar
|
|
7
|
Raoul JL, Gilabert M and Piana G: How to
define transarterial chemoembolization failure or refractoriness: A
European perspective. Liver Cancer. 3:119–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karczmarek-Borowska B and Sałek-Zan A:
Hepatotoxicity of molecular targeted therapy. Contemp Oncol (Pozn).
19:87–92. 2015.PubMed/NCBI
|
|
9
|
Vaitheesvaran B, Xu J, Yee J, Q-Y L, Go
VL, Xiao GG and Lee WN: The Warburg effect: A balance of flux
analysis. Metabolomics. 11:787–796. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gallamini A, Zwarthoed C and Borra A:
Positron emission tomography (PET) in oncology. Cancers (Basel).
6:1821–1889. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gauthe M, Richard-Molard M, Cacheux W,
Michel P, Jouve JL, Mitry E, Alberini JL and Lièvre A: Fédération
Francophone de Cancérologie Digestive (FFCD): Role of fluorine 18
fluorodeoxyglucose positron emission tomography/computed tomography
in gastrointestinal cancers. Dig Liver Dis. 47:443–454. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leffert HL and Paul D: Studies on primary
cultures of differentiated fetal liver cells. J Cell Biol.
52:559–568. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsumoto K, Yamada K, Kohmura E,
Kinoshita A and Hayakawa T: Role of pyruvate in ischaemia-like
conditions on cultured neurons. Neurol Res. 16:460–464. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohira RH, Dipple KM, Zhang YH and McCabe
ER: Human and murine glycerol kinase: Influence of exon 18
alternative splicing on function. Biochem Biophys Res Commun.
331:239–246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ai Y, Jenkins NA, Copeland NG, Gilbert DH,
Bergsma DJ and Stambolian D: Mouse galactokinase: Isolation,
characterization, and location on chromosome 11. Genome Res.
5:53–59. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wheatley DN, Scott L, Lamb J and Smith S:
Single amino acid (arginine) restriction: Growth and death of
cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem.
10:37–55. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu F, Huang J and Sui M: Targeting
arginine metabolism pathway to treat arginine-dependent cancers.
Cancer Lett. 364:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Phillips JW, Jones ME and Berry MN:
Implications of the simultaneous occurrence of hepatic glycolysis
from glucose and gluconeogenesis from glycerol. Eur J Biochem.
269:792–797. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sumida KD, Crandall SC, Chadha PL and
Qureshi T: Hepatic gluconeogenic capacity from various precursors
in young versus old rats. Metabolism. 51:876–880. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tomizawa M, Toyama Y, Ito C, Toshimori K,
Iwase K, Takiguchi M, Saisho H and Yokosuka O: Hepatoblast-like
cells enriched from mouse embryonic stem cells in medium without
glucose, pyruvate, arginine, and tyrosine. Cell Tissue Res.
333:17–27. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Survival of primary human
hepatocytes and death of induced pluripotent stem cells in media
lacking glucose and arginine. PLoS One. 8:e718972013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakamura T, Teramoto H, Tomita Y and
Ichihara A: L-proline is an essential amino acid for hepatocyte
growth in culture. Biochem Biophys Res Commun. 122:884–891. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu P, Tang R, Yu Z, Huang S, Xie M, Luo X
and Wang W: Bumetanide-induced NKCC1 inhibition attenuates
oxygen-glucose deprivation-induced decrease in proliferative
activity and cell cycle progression arrest in cultured OPCs via
P-38 MAPKs. Brain Res. 1613:110–119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gonzalez CD, Alvarez S, Ropolo A,
Rosenzvit C, Bagnes MF and Vaccaro MI: Autophagy, Warburg, and
Warburg reverse effects in human cancer. Biomed Res Int.
2014:9267292014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiu J, Zhou XY, Zhou XG, Li Y, Cheng R and
Liu HY: MicroRNA210 knockdown contributes to apoptosis caused by
oxygen glucose deprivation in PC12 cells. Mol Med Rep. 11:719–723.
2015.PubMed/NCBI
|
|
26
|
Wardi L, Alaaeddine N, Raad I, Sarkis R,
Serhal R, Khalil C and Hilal G: Glucose restriction decreases
telomerase activity and enhances its inhibitor response on breast
cancer cells: Possible extra-telomerase role of BIBR 1532. Cancer
Cell Int. 14:602014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim HS, Kim MJ, Lim J, Yang Y, Lee MS and
Lim JS: NDRG2 overexpression enhances glucose deprivation-mediated
apoptosis in breast cancer cells via inhibition of the LKB1-AMPK
pathway. Genes Cancer. 5:175–185. 2014.PubMed/NCBI
|
|
28
|
Elf SE and Chen J: Targeting glucose
metabolism in patients with cancer. Cancer. 120:774–780. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Feun LG, Kuo MT and Savaraj N: Arginine
deprivation in cancer therapy. Curr Opin Clin Nutr Metab Care.
18:78–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeng X, Li Y, Fan J, Zhao H, Xian Z, Sun
Y, Wang Z, Wang S, Zhang G and Ju D: Recombinant human arginase
induced caspase-dependent apoptosis and autophagy in non-Hodgkin's
lymphoma cells. Cell Death Dis. 4:e8402013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vynnytska-Myronovska B, Kurlishchuk Y,
Bobak Y, Dittfeld C, Kunz-Schughart LA and Stasyk O:
Three-dimensional environment renders cancer cells profoundly less
susceptible to a single amino acid starvation. Amino Acids.
45:1221–1230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eyo U and Dailey ME: Effects of
oxygen-glucose deprivation on microglial mobility and viability in
developing mouse hippocampal tissues. Glia. 60:1747–1760. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Imai N, Ishigami M, Ishizu Y, Kuzuya T,
Honda T, Hayashi K, Hirooka Y and Goto H: Transarterial
chemoembolization for hepatocellular carcinoma: A review of
techniques. World J Hepatol. 6:844–850. 2014. View Article : Google Scholar : PubMed/NCBI
|
